炎症性肠病患者平坦黏膜息肉周围活检评估
本研究回顾性分析56例炎症性肠病(IBD)患者,在切除异型增生息肉时对周围平坦黏膜活检。结果显示息肉周围活检异型增生检出率低(3.2%),且不能预测后续高度异型增生或癌风险;但息肉本身异型增生分级可预测后续进展期肿瘤。
要点
- IBD患者切除异型增生息肉时,周围平坦黏膜活检异型增生检出率仅3.2%。
- 息肉周围活检异型增生与后续高度异型增生或癌风险无显著关联(Pearson χ2 P=0.19)。
- 息肉异型增生分级可预测后续进展期肿瘤:低级别1、3、5年风险18%、29%、40%,高级别50%、60%、70%(HR 7.0)。
核心结论
- 在IBD相关结肠炎患者中,对离散异型增生息肉样病变邻近黏膜活检的检出率低,且不能预测随访检查所见;但息肉本身的异型增生分级可预测后续进展期肿瘤。
研究设计与样本
- 回顾性研究,纳入56例IBD患者(68%为溃疡性结肠炎),共进行102次结肠镜检查,切除129个异型增生息肉,并对周围平坦黏膜进行503次活检(平均每个息肉3.9个活检样本)。
主要发现
- 503次周围平坦黏膜活检中16次(3.2%)检出异型增生。
- 34例患者(21例溃疡性结肠炎)接受随访,中位随访1.7年(范围0.02-15年),共147次结肠镜检查。
- 基线结肠镜时息肉周围活检存在异型增生与后续高度异型增生或癌风险无显著关联(Pearson χ2检验P=0.19)。
- 异型增生息肉的大小和数量不能预测肿瘤结局;息肉样低级别异型增生后续进展期肿瘤1年、3年、5年概率分别为18%、29%、40%,息肉样高级别异型增生分别为50%、60%、70%(风险比7.0,标准误4.8)。
临床怎么用
- 作者结论指出,对IBD相关结肠炎患者离散异型增生息肉样病变邻近黏膜活检检出率低且不能预测随访所见,息肉本身异型增生分级可预测后续进展期肿瘤。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: When colon polyps are removed in the setting of inflammatory bowel disease (IBD) involving the large intestine, biopsy sampling of the flat mucosa surrounding such polyps have been recommended, but there are no data to support this practice. METHODS: We reviewed endoscopic and pathologic findings in IBD patients who had dysplastic polyps removed and biopsy sampling of the adjacent flat mucosa. We assessed risk for subsequent neoplasia based on the presence or absence of dysplasia in the peri-polyp flat mucosa and based on number and grade of index polypoid lesions. Kaplan-Meier survival analysis was performed. RESULTS: Fifty-six IBD patients (68% ulcerative colitis [UC]) underwent 102 colonoscopies, in which 129 dysplastic polyps were resected. Five hundred three biopsy procedures of the surrounding flat mucosa were performed (mean, 3.9 biopsy samples per polyp), of which 16 (3.2%) were dysplastic. Thirty-four patients (21 UC) had follow-up in a median of 1.7 years (range, .02-15) and 147 colonoscopies. The presence of dysplasia in peri-polyp biopsy specimens during index colonoscopy was not associated with risk of developing high-grade dysplasia (HGD) or cancer (Pearson χ2 test = .19). The size and number of dysplastic polyps were not predictive of neoplastic outcomes, but the probability of developing subsequent advanced neoplasia for polypoid low-grade dysplasia was 18%, 29%, and 40% by 1, 3, and 5 years, respectively, and for polypoid HGD was 50%, 60%, and 70% by 1, 3, and 5 years, respectively (hazard ratio, 7.0; standard error, 4.8). CONCLUSIONS: In patients with IBD-associated colitis, biopsy sampling of the mucosa adjacent to discrete dysplastic polypoid lesions are low yield and do not predict findings in follow-up examinations. However, the grade of dysplasia of the polyp itself is predictive of subsequent advanced neoplasia.
引用
- Krugliak Cleveland N, Huo D, Sadiq F, et al. Assessment of peri-polyp biopsy specimens of flat mucosa in patients with inflammatory bowel disease. Gastrointest Endosc. 2018. PMID: 29307473. doi:10.1016/j.gie.2017.12.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。